Please login to the form below
behavioural economics
This page shows the latest behavioural economics news and features for those working in and with pharma, biotech and healthcare.
Agile strategy or strategy for ‘agile’?
bring other elements such as design thinking or behavioural economics, enables teams to rapidly move forward as they know what to listen for and really connect Agile to the core of
Latest news
-
Behaviour change needs a quantified approach
The great mysteries of human behaviour and its often irrational quirks are slowly but surely being solved, thanks to a combination of behavioural economics and booming research in neuroscience. ... Putting behaviour change into action. The pharmaceutical
-
New philosophies driving transformative healthcare
This changing approach is also reflected in national 'population level' projects, like Change4life in the UK, which often use behavioural economics techniques to nudge people into leading healthier lifestyles so
-
Drug of choice
As the field of behavioural health economics continues to grow and gain influence over policy design, it should not escape us that the manner in which information is presented to patients
-
Things can only get better
It's all about behaviours. Behavioural economics is gaining a lot of traction in the adherence space.
-
Changing behaviours begins at home
Behavioural economics is becoming a key ingredient in developing a sustainable brand strategy. ... Start at the end. Behavioural economics is therefore becoming a key ingredient in developing a sustainable brand strategy - and it's all part of an
More from news
Approximately 1 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
Pharma conferences – will a hybrid version become the standard in 2021 and beyond?
Audience experiences will drive the future. There is an inter-related set of personal and corporate factors that will be the five key drivers of future behaviour: value, engagement, behavioural psychology, ... 5. Economics: Companies must decide the
-
Mapping the patient journey: eight ways to improve support programmes
5. Focus on behaviour – but do it holistically. Behavioural insights are critical to programme design. ... However, there’s still a tendency for companies to focus on one behaviour change model – they might be experts in nudges using behavioural
-
War games: why brand teams need a cunning plan that cannot fail
Pharma’s ability to factor behavioural understanding into strategic planning is potentially an area for improvement. ... of a behavioural economics model.
-
Nudge-nudge, think-think
2002 Nobel Prize winner Daniel Kahneman described Loss Aversion as ‘the most significant contribution of psychology to behavioural economics.’ Moreover, when Richard Thaler, pioneer of the Nudge Theory, won the 2017 ... The best behavioural change
-
How behavioural design is transforming the role and impact of life sciences in healthcare
Behavioural economics will become essential to the future success of life sciences companies. ... While organisations are experimenting, we are yet to see healthcare accelerate the adoption of behavioural economics.
More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest appointments
-
VMLY&Rx launches new payer agency in the US
She later transitioned into the agency setting with a focus on HCP, patient marketing, data analytics, behavioural science and health economics.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Article: How behavioural economics can help you build better brand communications
Combining behavioural economics, technology, and artificial intelligence can make a world of difference…. ... Behavioural economics is your chance to go deeper. The power of unspoken reactions.
-
We are looking for new talent! - Qual RM
Person Specification. Essential. Desirable. Qualifications. Bachelor’s Degree. Degree in areas such as; Psychology, biomedical science, behavioural economics.
-
Tackling obesity via green prescribing: A piece of cake or a half-baked strategy?
Research and policies should centre around behavioural economics, which focuses on the under-lying mechanisms that drive public choice. ... By channelling the resources that would have been spent on awareness raising into behavioural economics, companies
-
Silos – a reflection on the second birthday of Porterhouse Insights
At Porterhouse Insights, we have harnessed behavioural economics to create a custom monitoring tool: the Behaviour Promoter Score.
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
Could we turn flat, printed, instructive literature into engaging, interactive, bite size digital content using gamification while incorporating learnings from psychology and behavioural economics? ... Some patients do not consider themselves to be
More from PMHub
Approximately 3 fully matching, plus 18 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
